Antiangiogenic Therapy for Malignant Brain Tumors: Does It Still Matter?

PURPOSE OF REVIEW: To summarize the mechanisms of tumor angiogenesis and resistance to antiangiogenic therapy, and the influence on tumor microenvironment. RECENT FINDINGS: Several clinical trials have investigated the activity of anti-VEGF monoclonal antibodies and tyrosine kinase inhibitors in gli...

Descripción completa

Detalles Bibliográficos
Autores principales: Pellerino, Alessia, Bruno, Francesco, Soffietti, Riccardo, Rudà, Roberta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10256654/
https://www.ncbi.nlm.nih.gov/pubmed/37071295
http://dx.doi.org/10.1007/s11912-023-01417-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10256654/
https://www.ncbi.nlm.nih.gov/pubmed/37071295
http://dx.doi.org/10.1007/s11912-023-01417-1

Ejemplares similares